Your browser doesn't support javascript.
loading
First off Label Endovascular Clinical Experience to Treat Diffuse Cerebral Venous Sinus Thrombosis Using the INARI FlowTriever System: Case Report.
Bushnaq, Saif; Kareem, Samer Abdul; Liaw, Nicholas; Alenzi, Bader; Ahmed, Muhammad Khaleeq; Bushnaq, Merna; Zaidat, Osama O.
Affiliation
  • Bushnaq S; Texas Tech University Health Sciences Center, Lubbock, TX, United States.
  • Kareem SA; St Vincent Mercy Hospital, Neuroscience Institute, Toledo, OH, United States.
  • Liaw N; St Vincent Mercy Hospital, Neuroscience Institute, Toledo, OH, United States.
  • Alenzi B; St Vincent Mercy Hospital, Neuroscience Institute, Toledo, OH, United States.
  • Ahmed MK; Medical College of Georgia, Augusta, GA, United States.
  • Bushnaq M; King Hussein Cancer Center, Amman, Jordan.
  • Zaidat OO; St Vincent Mercy Hospital, Neuroscience Institute, Toledo, OH, United States.
Front Neurol ; 12: 778842, 2021.
Article in En | MEDLINE | ID: mdl-34975735
ABSTRACT
Anticoagulation with heparin is the current mainstay treatment for Cerebral Venous Sinus Thrombosis (CVST). Endovascular treatment is increasingly being used to treat patients with CVST who are non-responsive to anticoagulation. These more aggressive interventions include catheter-based local chemical thrombolysis, balloon angioplasty and mechanical thrombectomy with uncertain safety and efficacy. Here we describe the first reported clinical experience using the INARI FlowTriever system to treat a patient presented with focal weakness and found to have diffuse CVST.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Neurol Year: 2021 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Neurol Year: 2021 Document type: Article Affiliation country: United States